Oral-Systemic Link: Page 122

OSU gets $1M for head/neck cancer research
By DrBicuspid.com staff writers
Ohio State University (USU) has received a $1 million pledge to create an endowed chair in head and neck cancer research at its Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
June 22, 2011
African-Americans with thyroid cancer fare worse
By DrBicuspid.com staff writers
African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis and are more likely to die from it, according to a study in the spring issue of Ethnicity & Disease.
June 20, 2011
FDA unveils final cigarette warning labels
By DrBicuspid.com staff writers
Beginning September 2012, the U.S. Food and Drug Administration (FDA) will require larger, more prominent cigarette health warnings on all cigarette packaging and advertisements in the U.S.
June 20, 2011
2011 06 21 10 23 41 551 Fda Cigarette Warning
Rise in oropharyngeal cancer among men linked to HPV
By Donna Domino
A sharp rise in oropharyngeal cancer among men is being linked to human papillomavirus (HPV). If the trend continues, the number of HPV-positive oral cancers among U.S. men could rise by almost 30% by 2020, according to a new study from the National Cancer Institute.
June 20, 2011
2010 01 21 15 43 33 498 Salivary Glands 70
Appearance a key concern for oral cancer patients
By DrBicuspid.com staff writers
Patients' concerns about appearance following treatment of oral and oropharyngeal cancer and the impact this has on their quality of life are critical factors for practitioners to keep in mind when working with these patients, according to a study in the British Journal of Oral and Maxillofacial Surgery.
June 19, 2011
OralDNA Labs names new general manager
By DrBicuspid.com staff writers
OralDNA Labs has appointed Ken Clarke as general manager, the company announced.
June 13, 2011
New criteria help predict head/neck cancer treatment success
By DrBicuspid.com staff writers
Researchers from the Duke Cancer Institute and the University of Chicago have found a way to identify patients with recurring head and neck cancer who are most likely to benefit from a second round of chemotherapy and radiation, according to new study in the journal Cancer.
June 13, 2011
Palifermin decreases severe oral mucositis after radiotherapy
By Reuters Health
NEW YORK (Reuters Health) - Palifermin (Kepivance) helps reduce the rate, severity, and duration of severe oral mucositis in head and neck cancer patients receiving chemoradiotherapy, two new studies show.
June 13, 2011
Reuterslogo
Dentists can help ID patients with undiagnosed diabetes
By DrBicuspid.com staff writers
Dentists can help identify patients with diabetes or prediabetes who are unaware of their condition, according to researchers at the Columbia University College of Dental Medicine.
June 12, 2011
CEL-SCI extends clinical trials for head/neck cancer drug
By DrBicuspid.com staff writers
Pharmaceutical company CEL-SCI has begun phase III clinical trials for its immunotherapy drug Multikine in Hungary.
June 12, 2011
Ill. man sues after salivary gland surgery
By DrBicuspid.com staff writers
An Illinois man who underwent surgery to remove a salivary gland tumor is suing the hospital where the procedure was done, the surgeon who performed it, and a medical device company claiming he now has facial nerve paralysis after the doctor struck a facial nerve, according to a story in the Madison St. Clair Record.
June 9, 2011
Photodynamic therapy shows promise in head/neck cancer
By DrBicuspid.com staff writers
Photodynamic therapy has been shown to be effective as a curative therapy for early cancers of the head and neck, according to research presented at the recent International Photodynamic Association World Congress in Innsbruck, Austria.
June 9, 2011
Previous Page
Page 122 of 151
Next Page